Neuroprotective effects of NSTyr on cognitive function and neuronal plasticity in rats of chronic cerebral hypoperfusion

Brain Research

Volumn 1325, Issue , 2010, Pages 183-190

  Lin, Qi ^a   Hai, Jian ^b   Yao, Li Yun ^a   Lu, Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Chronic cerebral hypoperfusion; GAP 43; Long term potentiation; MAP 2; Neurodegeneration; NSTyr; Spatial memory; Synaptophysin

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; N STEAROYL LEVO TYROSINE; NEUROMODULIN; NEUROPROTECTIVE AGENT; STEARIC ACID; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; BRAIN REGION; CHRONIC CEREBRAL HYPOPERFUSION; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LONG TERM POTENTIATION; MAZE TEST; MEMORY DISORDER; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; STAINING; WESTERN BLOTTING;

ANIMALS; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; COGNITION; DISEASE MODELS, ANIMAL; GAP-43 PROTEIN; HIPPOCAMPUS; LONG-TERM POTENTIATION; MAZE LEARNING; MEMORY DISORDERS; MICROTUBULE-ASSOCIATED PROTEINS; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SPACE PERCEPTION; SYNAPTOPHYSIN; TYROSINE;

RATTUS;

EID: 77949915141     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.02.037     Document Type: Article

References (38)

1. Aliev G., Gasimov E., Obrenovich M.E., Fischbach K., Shenk J.C., Smith M.A., and Perry G. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vasc. Health Risk Manag. 4 (2009) 721-730
2. Baker D., Pryce G., Giovannoni G., and Thompson A.J. The therapeutic potential of cannabis. Lancet Neurol. 2 (2003) 291-298
3. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
4. Blumberg S., and Vallee B.L. Superactivation of thermolysin by acylation with amino acid N-hydroxysuccinimide esters. Biochem. 14 (1975) 2410-2419
5. Burstein S.H., Rossetti R.G., Yagen B., and Zurier R.B. Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat. 61 (2000) 29-41
6. Burstein S.H., Huang S.M., Petros T.J., Rossetti R.G., Walker J.M., and Zurier R.B. Regulation of anandamide tissue levels by N-arachidonylglycine. Biochem. Pharmacol. 64 (2002) 1147-1150
7. Burstein S.H., Adams J.K., Bradshaw H.B., Fraioli C., Rossetti R.G., Salmonsen R.A., Shaw J.W., Walker J.M., Zipkin R.E., and Zurier R.B. Potential anti-inflammatory actions of the elmiric (lipoamino) acids. Bioorg. Med. Chem. 15 (2007) 3345-3355
8. Dawson D.A., and Hallenbeck J.M. Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J. Cereb. Blood Flow Metab. 16 (1996) 170-174
9. Ding Y., Li J., Clark J., Diaz F.G., and Rafols J.A. Synaptic plasticity in thalamic nuclei enhanced by motor skill training in rat with transient middle cerebral artery occlusion. Neurol. Res. 25 (2003) 189-194
10. Farkas E., de Wilde M.C., Kiliaan A.J., and Luiten P.G. Chronic cerebral hypoperfusion-related neuropathologic changes and compromised cognitive status: window of treatment. Drugs Today (Barc.) 38 (2002) 365-376
11. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55 (2008) 363-389
12. Guzman M. Effects on cell viability. Handle Exp. Pharmacol. 168 (2005) 627-642
13. Hai J., Ding M.X., Guo Z.L., and Wang B.Y. A new rat model of chronic cerebral hypoperfusion associated with arteriovenous malformations. J. Neurosurg. 97 (2002) 1198-1202
14. Hai J., Wan J.F., Lin Q., Wang F., Zhang L., Li H., Zhang L., Chen Y.Y., and Weber N.C. Cognitive dysfunction induction by chronic cerebral hypoperfusion in a rat model associated with arteriovenous malformations. Brain Res. 1301 (2009) 80-88
15. Hainsworth A.H., and Markus H.S. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J. Cereb. Blood Flow Metab. 28 (2008) 1877-1891
16. Hasumi T., Fukushima T., Haisa T., Yonemitsu T., and Waragai M. Focal dural arteriovenous fistula (DAVF) presenting with progressive cognitive impairment including amnesia and alexia. Intern. Med. 46 (2007) 1317-1320
17. Huang S.M., Bisogno T., Petros T.J., Chang S.Y., Zavitsanos P.A., Zipkin R.E., Sivakumar R., Coop A., and Walker J.M. Identification of a new class of molecules, the arachidontyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 276 (2001) 42639-42644
18. Liu H.X., Zhang J.J., Zheng P., and Zhang Y. Altered expression of MAP-2, GAP-43, and synaptophsin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment. Mol. Brain Res. 139 (2005) 169-177
19. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutiérrez S.O., van der Stelt M., López-Rodriguez M.L., Casanova E., Schütz G., Zieglgänsberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
20. Meyer B., Schaller C., Frenkel C., Ebeling B., and Schramm J. Distributions of local oxygen saturation and its response to changes of mean arterial blood pressure in the cerebral cortex adjacent to arteriovenous malformations. Stroke 30 (1999) 2623-2630
21. Micale V., Mazzola C., and Drago F. Endocannabinoids and neurodegenerative diseases. Pharmacol. Res. 56 (2007) 382-392
22. Mori K., Togashi H., Ueno K., Matsumoto M., and Yoshioka M. Aminoguanidine prevented the impairment of learning behavior and hippocampal long-term potentiation following transient cerebral ischemia. Behav. Brain Res. 120 (2001) 159-168
23. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
24. Nunn J.A., LePeillet E., Netto C.A., Hodges H., Gray J.A., and Meldrum B.S. Global ischaemia: hippocampal pathology and spatial deficits in the water maze. Behav. Brain Res. 62 (1994) 41-54
25. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, London, UK
26. Roush W. New knockout mice point to molecular basis of memory. Science 275 (1997) 32-33
27. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neruonal degeneration. Brain Res. 874 (2000) 123-130
28. Schmued L.C., Albertson C., and Slikker Jr. W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751 (1997) 37-46
29. Sekhon L.H., Spence I., Morgan M.K., and Weber N.C. Long-term potentiation saturation in chronic cerebral hypoperfusion. J. Clin. Neurosci. 5 (1998) 323-328
30. Stevens C.F. Spatial learning and memory: the beginning of a dream. Cell 87 (1996) 1147-1148
31. Strittmatter S.M., Vartanian T., and Fishman M.C. GAP-43 as a plasticity protein in neuronal form and repair. J. Neurobiol. 23 (1992) 507-520
32. Tucker R.P. The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res. Rev. 15 (1990) 101-120
33. van der Stelt M., and Di Marzo V. Cannabinoid receptors and their role in neuroprotection. Neuromolecular Med. 7 (2005) 37-50
34. Wang Z.J., Li G.M., Tang W.L., and Yin M. Neuroprotective effects of stearic acid against toxicity of oxygen/glucose deprivation or glutamate on rat cortical or hippocampal slices. Acta Pharmacol. Sin. 27 (2006) 145-150
35. Wang Z.J., Liang C.L., Li G.M., Yu C.Y., and Yin M. Stearic acid protects primary cultured cortical neurons against oxidative stress. Acta Pharmacol. Sin. 28 (2007) 315-326
36. Yao L.Y., Lin Q., Niu Y.Y., Deng K.M., Zhang J.H., and Lu Y. Synthesis of lipoamino acids and their activity against cerebral ischemic injury. Molecules 14 (2009) 4051-4064
37. Yoshioka M., Itoh Y., Mori K., Ueno K.I., Matsumoto M., and Togashi H. Effects of an interleulin-1β analogue [Lys-D-Pro-Thr], on incomplete cerebral ischemia-induced inhibition of long-term potentiation in rat hippocampal neurons in vive. Neurosci. Lett. 261 (1999) 171-174
38. Zhang Y.B., Kan M.Y., Yang Z.H., Ding W.L., Yi J., Chen H.Z., and Lu Y. Neuroprotective effects of N-stearoyltyrosine on transient global cerebral ischemia in gerbils. Brain Res. 1287 (2009) 146-156